{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:53:38Z","timestamp":1793753618135,"version":"4.6.1"},"reference-count":233,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijo.ijo_1240_18","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T05:29:55Z","timestamp":1542778195000},"page":"1736","source":"Crossref","is-referenced-by-count":202,"title":["Diabetic macular edema: Evidence-based management"],"prefix":"10.4103","volume":"66","author":[{"given":"MichaelW","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DavidJ","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.245608-1","doi-asserted-by":"crossref","unstructured":"Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7-16.","DOI":"10.1016\/S0161-6420(95)31052-4"},{"key":"key-10.4103\/0301-4738.245608-2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0161-6420(92)32011-1","article-title":"The beaver dam eye study.Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-3","doi-asserted-by":"crossref","unstructured":"Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989;96:1501-10.","DOI":"10.1016\/S0161-6420(89)32699-6"},{"key":"key-10.4103\/0301-4738.245608-4","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00417-008-0884-6","article-title":"Prevalence and associated factors of diabetic retinopathy.The Beijing eye study 2006","author":"Xie","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pcd.2007.02.002","article-title":"Diagnosed diabetic retinopathy in France, Italy, Spain, and the United Kingdom","author":"Rubino","year":"2007","journal-title":"Prim Care Diabetes"},{"key":"key-10.4103\/0301-4738.245608-6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ajo.2005.08.063","article-title":"Diabetic retinopathy in a multi-ethnic cohort in the United States","author":"Wong","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ophtha.2004.03.002","article-title":"Prevalence of diabetic retinopathy in adult Latinos: The Los Angeles Latino eye study","author":"Varma","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0301-4738.245608-9","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0161-6420(98)91020-X","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy: XVII.The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes","author":"Klein","year":"1998","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/112067210201200606","article-title":"Macular thickness measured by optical coherence tomography (OCT) in diabetic patients","author":"Lattanzio","year":"2002","journal-title":"Eur J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ophtha.2007.06.042","article-title":"The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema","author":"Browning","year":"2008","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/jamaophthalmol.2013.5024","article-title":"Challenges in elucidating the genetics of diabetic retinopathy","author":"Kuo","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-13","first-page":"1698","article-title":"Relation between superficial capillaries and foveal structures in the human retina","author":"Iwasaki","year":"1986","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cne.902970111","article-title":"Retinal vasculature of the fovea of the squirrel monkey, Saimiri sciureus: Three-dimensional architecture, visual screening, and relationships to the neuronal layers","author":"Snodderly","year":"1990","journal-title":"J Comp Neurol"},{"key":"key-10.4103\/0301-4738.245608-15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.oret.2017.07.022","article-title":"OCT angiography changes in the 3 parafoveal retinal plexuses in response to hyperoxia","author":"Hagag","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"key-10.4103\/0301-4738.245608-16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1469-7580.1999.19410089.x","article-title":"Three dimensional analysis of microaneurysms in the human diabetic retina","author":"Moore","year":"1999","journal-title":"J Anat"},{"key":"key-10.4103\/0301-4738.245608-17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.eye.6702801","article-title":"Correlation between microaneurysm closure rate and reduction in macular thickness following laser photocoagulation of diabetic macular edema","author":"Sachdev","year":"2008","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245608-18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ophtha.2013.10.034","article-title":"Abnormal deep retinal capillary networking and microaneurysms in the outer nuclear layer of diabetic eyes","author":"Querques","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-19","doi-asserted-by":"crossref","unstructured":"Browning DJ, editor. Diabetic macular edema. In: Diabetic Retinopathy, Evidence-Based Management. 1st ed., Ch. 7. New York: Springer Inc.; 2010.","DOI":"10.1007\/978-0-387-85900-2_7"},{"key":"key-10.4103\/0301-4738.245608-20","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/bjo.2003.035345","article-title":"Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes","author":"Nagaoka","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02280087","article-title":"Diabetic choroidal and iris vasculature scanning electron microscopy findings","author":"Fryczkowski","year":"1989","journal-title":"Int Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/38.9.2117624","article-title":"Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats","author":"Vinores","year":"1990","journal-title":"J Histochem Cytochem"},{"key":"key-10.4103\/0301-4738.245608-23","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S0039-6257(02)00387-9","article-title":"Diabetic retinopathy: More than meets the eye","author":"Gardner","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-24","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0161-6420(88)33004-6","article-title":"The role of the vitreous in diabetic macular edema","author":"Nasrallah","year":"1988","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-25","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1097\/IAE.0b013e31825bc704","article-title":"Role of vitreous in diabetic macular edema","author":"Gandorfer","year":"2012","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ajo.2004.11.035","article-title":"Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction","author":"Gandorfer","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-27","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/bjo.79.8.728","article-title":"Non-retinovascular leakage in diabetic maculopathy","author":"Weinberger","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-28","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)65044-4","article-title":"Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1)","author":"Miyamoto","year":"2000","journal-title":"Am J Pathol"},{"key":"key-10.4103\/0301-4738.245608-29","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.96.19.10836","article-title":"Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition","author":"Miyamoto","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0301-4738.245608-30","first-page":"433","article-title":"Diabetic macular edema: Passive and active transport of fluorescein through the blood-retina barrier","author":"Sander","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-31","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1016\/S0039-6257(02)00386-7","article-title":"Mechanisms for monitoring changes in retinal status following therapeutic intervention in diabetic retinopathy","author":"Lund-Andersen","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.survophthal.2006.04.005","article-title":"Ocular oxygenation and the treatment of diabetic retinopathy","author":"Stef\u00e1nsson","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bjo.81.4.274","article-title":"Retinal vessel dilatation and elongation precedes diabetic macular oedema","author":"Kristinsson","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-34","first-page":"36","article-title":"Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy","author":"Amin","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9440(10)63952-1","article-title":"Leukocyte-mediated endothelial cell injury and death in the diabetic retina","author":"Joussen","year":"2001","journal-title":"Am J Pathol"},{"key":"key-10.4103\/0301-4738.245608-36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2008.09.037","article-title":"Association of vitreous inflammatory factors with diabetic macular edema","author":"Funatsu","year":"2009","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bjo.84.5.542","article-title":"Macular oedema: The role of soluble mediators","author":"Kent","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/bjo.2005.087403","article-title":"Diabetic cataract removal: Postoperative progression of maculopathy \u2013 Growth factor and clinical analysis","author":"Patel","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","author":"Tang","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"key-10.4103\/0301-4738.245608-40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00006982-199515020-00008","article-title":"Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy.A pilot study","author":"Gardner","year":"1995","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ajo.2006.05.061","article-title":"Antivascular endothelial growth factor agents and their development: Therapeutic implications in ocular diseases","author":"Kaiser","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-42","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.2337\/diabetes.53.11.2883","article-title":"A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes","author":"Miljanovic","year":"2004","journal-title":"Diabetes"},{"key":"key-10.4103\/0301-4738.245608-43","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/archopht.1992.01080220134035","article-title":"Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy","author":"Sebag","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0039-6257(84)90231-5","article-title":"Pathogenesis of cystoid macular edema: An anatomic consideration of vitreoretinal adhesions","author":"Sebag","year":"1984","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-9394(00)00872-2","article-title":"Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction","author":"Kaiser","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0002-9394(02)01548-9","article-title":"A controlled study of vitrectomy for diabetic macular edema","author":"Otani","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ajo.2004.09.046","article-title":"Vitrectomy surgery increases oxygen exposure to the lens: A possible mechanism for nuclear cataract formation","author":"Holekamp","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0002-9394(02)01837-8","article-title":"Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy","author":"Massin","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-49","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0002-9394(00)00575-4","article-title":"Perifoveal microcirculation before and after vitrectomy for diabetic cystoid macular edema","author":"Kadonosono","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-50","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1167\/iovs.04-0767","article-title":"Laser-induced changes in intraretinal oxygen distribution in pigmented rabbits","author":"Yu","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-51","first-page":"69","article-title":"Diabetic macular edema: A critical review of the early treatment diabetic retinopathy study (ETDRS) series and subsequent studies","author":"Browning","year":"2000","journal-title":"Comp Ophthalmol Update"},{"key":"key-10.4103\/0301-4738.245608-52","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00417-007-0646-x","article-title":"Retinal function and PKC alpha expression after focal laser photocoagulation","author":"Wallent\u00e9n","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-53","first-page":"2408","article-title":"VEGF-initiated blood-retinal barrier breakdown in early diabetes","author":"Qaum","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-54","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/db07-0982","article-title":"Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"key-10.4103\/0301-4738.245608-55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.visres.2003.09.027","article-title":"Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina","author":"Gao","year":"2004","journal-title":"Vision Res"},{"key":"key-10.4103\/0301-4738.245608-56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(97)01464-7","article-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells","author":"Nauck","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0301-4738.245608-57","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1167\/iovs.04-0905","article-title":"Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina","author":"Tamura","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-58","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0092-8674(90)90396-V","article-title":"Transcriptional interference between c-jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction","author":"Yang-Yen","year":"1990","journal-title":"Cell"},{"key":"key-10.4103\/0301-4738.245608-59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.exer.2004.09.013","article-title":"Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown","author":"Edelman","year":"2005","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/0301-4738.245608-60","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajo.2006.01.044","article-title":"How does vitrectomy affect diabetic macular edema?","author":"Stef\u00e1nsson","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0002-9394(00)00660-7","article-title":"The role of vitrectomy in the treatment of diabetic macular edema","author":"Lewis","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-62","first-page":"761","article-title":"Early Treatment Diabetic Retinopathy Study Report Number 2.Early Treatment Diabetic Retinopathy Study Research Group","author":"Treatment","year":"1987","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-63","first-page":"1796","article-title":"Early treatment diabetic retinopathy study report number 1.Early treatment diabetic retinopathy study research group","author":"Photocoagulation","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-64","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00417-004-1059-8","article-title":"The effect of intravitreal triamcinolone on diabetic macular oedema","author":"Krepler","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-65","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.eye.6701636","article-title":"Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation","author":"Negi","year":"2005","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245608-66","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ophtha.2004.12.039","article-title":"Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema","author":"Tunc","year":"2005","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-67","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bjo.2004.041707","article-title":"Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: An optical coherence tomography study","author":"Ciardella","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-68","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00006982-200412000-00010","article-title":"Retrobulbar injection of methylprednisolone in diffuse diabetic macular edema","author":"Knudsen","year":"2004","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00417-005-0069-5","article-title":"Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates","author":"Avci","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00006982-198500520-00001","article-title":"Grid photocoagulation for diffuse macular edema","author":"McDonald","year":"1985","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-72","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/01.iae.0000247165.38655.bf","article-title":"Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema","author":"Haritoglou","year":"2006","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-73","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ophtha.2006.12.028","article-title":"Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: Results from the pan-american collaborative retina study group at 6-month follow-up","author":"Arevalo","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-74","doi-asserted-by":"crossref","unstructured":"Bailey CC, Sparrow JM, Grey RH, Cheng H. The national diabetic retinopathy laser treatment audit. I. Maculopathy. Eye (Lond) 1998;12(Pt 1):69-76.","DOI":"10.1038\/eye.1998.13"},{"key":"key-10.4103\/0301-4738.245608-75","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00417-006-0456-6","article-title":"Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema","author":"Kumar","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-76","first-page":"97","article-title":"Laser photocoagulation control of diabetic macular oedema without fluorescein angiography","author":"Abu","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-77","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/sj.eye.6701969","article-title":"Progressive changes in diabetics and their management","author":"Aylward","year":"2005","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245608-78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00006982-200602000-00002","article-title":"Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema","author":"Zein","year":"2006","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-79","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0161-6420(86)33650-9","article-title":"Diabetic macular edema.A review","author":"Bresnick","year":"1986","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-80","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajo.2007.09.029","article-title":"Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema","author":"Gaucher","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-81","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.eye.6702152","article-title":"Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema","author":"Bardak","year":"2006","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245608-82","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/bjo.84.8.871","article-title":"Maculopathy in patients with diabetes mellitus type 1 and type 2: Associations with risk factors","author":"Zander","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-83","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/1080768041725308","article-title":"A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema","author":"Verma","year":"2004","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.245608-84","first-page":"1","article-title":"Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin","author":"Berman","year":"1994","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-85","first-page":"3655","article-title":"Retinal function in diabetic macular edema after focal laser photocoagulation","author":"Greenstein","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-86","first-page":"3643","article-title":"The nature and extent of retinal dysfunction associated with diabetic macular edema","author":"Greenstein","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-87","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ajo.2004.12.084","article-title":"Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema","author":"Gaucher","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-88","doi-asserted-by":"crossref","unstructured":"Browning DJ, Altaweel MM, Bressler NM, Bressler SB, Scott IU; Diabetic Retinopathy Clinical Research Network, et al. Diabetic macular edema: What is focal and what is diffuse? Am J Ophthalmol 2008;146:649-55, 655.e1-6.","DOI":"10.1016\/j.ajo.2008.07.013"},{"key":"key-10.4103\/0301-4738.245608-89","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(99)00033-1","article-title":"Patterns of diabetic macular edema with optical coherence tomography","author":"Otani","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-90","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/IAE.0000000000001648","article-title":"Intravitreal dexamethasone implantation in patients with different morphological diabetic macular edema having insufficient response to ranibizumab","author":"Kald\u0131r\u0131m","year":"2018","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-91","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ophtha.2003.06.028","article-title":", O'Marah TL.Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography","author":"Browning","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-92","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.122.3.330","article-title":"Detection of diabetic foveal edema: Contact lens biomicroscopy compared with optical coherence tomography","author":"Brown","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ajo.2007.08.038","article-title":"The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema","author":"Browning","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-94","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.eye.6701945","article-title":"Pars plana vitrectomy for diabetic macular oedema: OCT and functional correlations","author":"Patel","year":"2006","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245608-95","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00417-004-0958-z","article-title":"Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid","author":"Rosenblatt","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-96","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamaophthalmol.2017.4914","article-title":"Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema: A DRCR network phase 2 randomized clinical trial","author":"Maturi","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-97","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jamaophthalmol.2017.6565","article-title":"Persistent macular thickening following intravitreous aflibercept, bevacizumab, or ranibizumab for central-involved diabetic macular edema with vision impairment: A secondary analysis of a randomized clinical trial","author":"Bressler","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-98","first-page":"295","article-title":"Vitrectomy for persistent diffuse diabetic macular edema","author":"Stolba","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-99","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ajo.2004.09.076","article-title":"Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema","author":"Recchia","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-100","first-page":"72","article-title":"A comparison of fundus biomicroscopy and 90 diopter lens examination in the detection of diabetic macular edema","author":"Brun","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-101","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3129\/i06-066","article-title":"Benefits of stereopsis when identifying clinically significant macular edema via teleophthalmology","author":"Rudnisky","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-102","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0161-6420(99)00010-X","article-title":"A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopathy","author":"Bresnick","year":"2000","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-103","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1167\/iovs.08-2231","article-title":"A severity scale for diabetic macular edema developed from ETDRS data","author":"Gangnon","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-104","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1167\/iovs.07-1257","article-title":"Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema","author":"Davis","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-105","first-page":"260","article-title":"Reply to letter","author":"Gupta","year":"1997","journal-title":"Ind J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jdiacomp.2008.02.010","article-title":"Comparison of dilated fundus examinations with seven-field stereo fundus photographs in the veterans affairs diabetes trial","author":"Emanuele","year":"2009","journal-title":"J Diabetes Complications"},{"key":"key-10.4103\/0301-4738.245608-107","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ajo.2003.12.013","article-title":"Interobserver variability in optical coherence tomography for macular edema","author":"Browning","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-108","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ajo.2004.03.014","article-title":"Intraobserver variability in optical coherence tomography","author":"Browning","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-109","first-page":"1520","article-title":"Reproducibility of macular thickness and volume using zeiss optical coherence tomography in patients with diabetic macular edema","author":"Diabetic","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-110","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archopht.119.8.1135","article-title":"Reproducibility of retinal mapping using optical coherence tomography","author":"Massin","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-111","first-page":"1486","article-title":"Intersession repeatability of macular thickness measurements with the humphrey 2000 OCT","author":"Koozekanani","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-112","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ajo.2008.01.007","article-title":"The variation in optical coherence tomography-measured macular thickness in diabetic eyes without clinical macular edema","author":"Browning","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-113","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: Preliminary results of a prospective controlled trial","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-114","doi-asserted-by":"crossref","unstructured":"Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, et al. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology 2008;115:1366-71, 1371.e1.","DOI":"10.1016\/j.ophtha.2007.12.004"},{"key":"key-10.4103\/0301-4738.245608-115","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/archopht.123.7.939","article-title":"A standardized method for reporting changes in macular thickening using optical coherence tomography","author":"Chan","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-116","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archopht.1995.01100080071031","article-title":"Quantitative assessment of macular edema with optical coherence tomography","author":"Hee","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-117","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1167\/iovs.08-2113","article-title":"Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema","author":"Forooghian","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-118","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3928\/15428877-20090301-09","article-title":"Comparison of macular thickness between cirrus HD-OCT and stratus OCT","author":"Kakinoki","year":"2009","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key-10.4103\/0301-4738.245608-119","first-page":"S43","article-title":"Macular thickness measurements in normal eyes using spectral domain optical coherence tomography","author":"Legarreta","year":"2008","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key-10.4103\/0301-4738.245608-120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajo.2017.09.030","article-title":"Diabetic choroidopathy: Choroidal vascular density and volume in diabetic retinopathy with swept-source optical coherence tomography","author":"Wang","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-121","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/tvst.6.1.9","article-title":"Platform-independent cirrus and spectralis thickness measurements in eyes with diabetic macular edema using fully automated software","author":"Willoughby","year":"2017","journal-title":"Transl Vis Sci Technol"},{"key":"key-10.4103\/0301-4738.245608-122","first-page":"5339","article-title":"Cellular and functional optical coherence tomography of the human retina: The Cogan lecture","author":"Drexler","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-123","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/eye.2011.293","article-title":"Spectral- and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edema","author":"Ibrahim","year":"2012","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245608-124","first-page":"525","article-title":"Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema","author":"Diabetic","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IAE.0b013e3181bd2c5a","article-title":"Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema","author":"Forooghian","year":"2010","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-126","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/IAE.0000000000001599","article-title":"Outer retinal layer thickness as good visual predictor in patients with diabetic macular edema","author":"Eliwa","year":"2018","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-127","first-page":"981471","article-title":"Relationship between outer retinal layers thickness and visual acuity in diabetic macular edema","author":"Wong","year":"2015","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/0301-4738.245608-128","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaophthalmol.2014.2350","article-title":"Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema","author":"Sun","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-129","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/IAE.0000000000001626","article-title":"Predictive value of optical coherence tomographic features in the bevacizumab and ranibizumab in patients with diabetic macular edema (Brdme) study","author":"Fickweiler","year":"2018","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jamaophthalmol.2017.6256","article-title":"Disorganization of inner retina and outer retinal morphology in diabetic macular edema","author":"Das","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-131","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/IAE.0000000000001459","article-title":"Integrity of outer retinal layers after resolution of central involved diabetic macular edema","author":"Muftuoglu","year":"2017","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-132","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00417-012-1968-x","article-title":"External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy","author":"Chhablani","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-133","first-page":"675","article-title":"Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema","author":"Gupta","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-134","doi-asserted-by":"crossref","unstructured":"Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD, et al. Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early treatment diabetic retinopathy study research group. Arch Ophthalmol 1997;115:873-7.","DOI":"10.1001\/archopht.1997.01100160043006"},{"key":"key-10.4103\/0301-4738.245608-135","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/IAE.0b013e318159e7d2","article-title":"Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema","author":"Figueroa","year":"2008","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-136","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0002-9394(14)70437-4","article-title":", Rubsamen PE.Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane","author":"Harbour","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-137","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00006982-200402000-00004","article-title":"Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy","author":"Takaya","year":"2004","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-138","first-page":"647","article-title":"Diabetes control and complications trial research group","author":"Progression","year":"1995","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-139","doi-asserted-by":"crossref","unstructured":"Early worsening of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol 1998;116:874-86.","DOI":"10.1001\/archopht.116.7.874"},{"key":"key-10.4103\/0301-4738.245608-140","first-page":"837","article-title":"UK prospective diabetes study (UKPDS) group","author":"Intensive","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/0301-4738.245608-141","first-page":"703","article-title":"UK prospective diabetes study group","author":"Tight","year":"1998","journal-title":"BMJ"},{"key":"key-10.4103\/0301-4738.245608-142","doi-asserted-by":"crossref","unstructured":"Klein BE, Moss SE, Klein R, Surawicz TS. The Wisconsin epidemiologic study of diabetic retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991;98:1261-5.","DOI":"10.1016\/S0161-6420(91)32145-6"},{"key":"key-10.4103\/0301-4738.245608-143","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archopht.1996.01100140281004","article-title":"Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy.Early treatment diabetic retinopathy study (ETDRS) report 22","author":"Chew","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-144","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000310581","article-title":"Influence of serum lipid fractions on the course of diabetic macular edema after photocoagulation","author":"Kremser","year":"1995","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.245608-145","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2337\/diabetes.50.5.1166","article-title":"Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes","author":"Emoto","year":"2001","journal-title":"Diabetes"},{"key":"key-10.4103\/0301-4738.245608-146","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archophthalmol.2009.310","article-title":", Greven CM, Gerstein HC, Cohen RM, et al. Lack of association between thiazolidinediones and macular edema in type 2 diabetes: The ACCORD eye substudy","author":"Ambrosius","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-147","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ajo.2017.12.007","article-title":"Lack of longitudinal association between thiazolidinediones and incidence and progression of diabetic eye disease: The ACCORD eye study","author":"Gower","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-148","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diacare.29.02.06.dc05-1931","article-title":"Effect of multifactorial intervention on diabetic macular edema","author":"Singh","year":"2006","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0301-4738.245608-149","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archopht.1991.01080110085041","article-title":"Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema","author":"Schatz","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-150","first-page":"652","article-title":"Subretinal fibrosis after laser photocoagulation for diabetic macular edema","author":"Guyer","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-151","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9394(14)74722-1","article-title":"Submacular fibrosis after photocoagulation for diabetic macular edema","author":"Han","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-152","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0161-6420(90)32574-5","article-title":"Choroidal neovascularization after laser photocoagulation for diabetic macular edema","author":"Lewis","year":"1990","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-153","first-page":"761","article-title":"Early treatment diabetic retinopathy study report number 2.Early treatment diabetic retinopathy study research group","author":"Treatment","year":"1987","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-154","first-page":"1860","article-title":"A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema","author":"Diabetic","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-155","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ophtha.2006.05.021","article-title":"Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: Implications for sequence of application","author":"Browning","year":"2006","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-156","first-page":"1190","article-title":"Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: A pilot study","author":"Diabetic","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-157","doi-asserted-by":"crossref","unstructured":"Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-9, 1449.e1-10.","DOI":"10.1016\/j.ophtha.2008.06.015"},{"key":"key-10.4103\/0301-4738.245608-158","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/bjo.2003.040949","article-title":"Subthreshold micropulse diode laser treatment in diabetic macular oedema","author":"Laursen","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-159","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/bjo.2004.051540","article-title":"Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema","author":"Luttrull","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-160","doi-asserted-by":"crossref","unstructured":"Akduman L, Olk RJ. Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME) Ophthalmic Surg Lasers 1999;30:706-14.","DOI":"10.3928\/1542-8877-19991101-04"},{"key":"key-10.4103\/0301-4738.245608-161","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/IAE.0b013e3182206f6c","article-title":"Long-term safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema","author":"Luttrull","year":"2012","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-162","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","article-title":"Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema","author":"Jonas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-163","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ophtha.2006.02.065","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema: Two-year results of a double-masked, placebo-controlled, randomized clinical trial","author":"Gillies","year":"2006","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-164","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-165","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ajo.2006.06.011","article-title":"Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: Phase 2 trial comparing 4 mg vs.2 mg","author":"Audren","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-166","first-page":"695","article-title":"Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema","author":"Avitabile","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-167","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bjo.2006.102848","article-title":"A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema","author":"Lam","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-168","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/IAE.0000000000001004","article-title":"Intraocular pressure in patients with diabetic macular edema treated with dexamethasone intravitreal implant in the 3-year mead study","author":"Maturi","year":"2016","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-169","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":", Bandello F, Maturi RK, Augustin AJ, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajo.2017.10.004","article-title":"Early response to intravitreal dexamethasone implant therapy in diabetic macular edema may predict visual outcome","author":"Al-Khersan","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-171","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ophtha.2010.12.028","article-title":"Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-172","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/IAE.0000000000001000","article-title":"Intravitreal injections of ziv-aflibercept for diabetic macular edema: A pilot study","author":"Andrade","year":"2016","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-173","first-page":"577","article-title":"Preclinical investigations of intravitreal ziv-aflibercept","author":"de","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.4103\/0301-4738.245608-174","first-page":"1193","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","author":"Diabetic","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.245608-175","first-page":"245","article-title":"Intravitreal ziv-aflibercept for diabetic macular edema: 48-week outcomes","author":"de","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.4103\/0301-4738.245608-176","first-page":"1747","article-title":", Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema","author":"Cunningham","year":"2005","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-177","first-page":"972","article-title":"A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: Report 3","author":"Rajendram","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-178","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-179","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2015.06.017","article-title":"Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies","author":"Brown","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-180","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: Two-year results from a comparative effectiveness randomized clinical trial","author":"Wells","year":"2016","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-181","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/eye.2015.142","article-title":"Month-6 primary outcomes of the READ-3 study (Ranibizumab for edema of the mAcula in diabetes-protocol 3 with high dose)","author":"Do","year":"2015","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245608-182","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.ophtha.2016.08.040","article-title":"Twenty-four-month outcomes of the ranibizumab for edema of the macula in diabetes \u2013 Protocol 3 with high dose (READ-3) study","author":"Sepah","year":"2016","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-183","doi-asserted-by":"crossref","unstructured":"Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-1077.e35.","DOI":"10.1016\/j.ophtha.2010.02.031"},{"key":"key-10.4103\/0301-4738.245608-184","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ophtha.2015.02.006","article-title":"The REVEAL study: Ranibizumab monotherapy or combined with laser versus laser monotherapy in Asian patients with diabetic macular edema","author":"Ishibashi","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-185","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jamaophthalmol.2015.5346","article-title":"Persistent macular thickening after ranibizumab treatment for diabetic macular edema with vision impairment","author":"Bressler","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-186","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ophtha.2017.06.029","article-title":"Baseline factors affecting changes in diabetic retinopathy severity scale score after intravitreal aflibercept or laser for diabetic macular edema: Post hoc analyses from VISTA and VIVID","author":"Dhoot","year":"2018","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-187","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1167\/iovs.12-11503","article-title":"Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients","author":"Kim","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-188","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/IAE.0b013e3182979b9e","article-title":"Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy","author":"Chae","year":"2014","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-189","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/02713683.2013.867064","article-title":"Changes of choroidal thickness after treatment for diabetic retinopathy","author":"Lee","year":"2014","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/0301-4738.245608-190","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ajo.2014.06.006","article-title":"Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema","author":"Yiu","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-191","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/IAE.0000000000001645","article-title":"Changes in central choroidal thickness after treatment of diabetic macular edema with intravitreal bevacizumab correlation with central macular thickness and best-corrected visual acuity","author":"Nourinia","year":"2018","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-192","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/2013.jamaophthalmol.91","article-title":"Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment","author":"Do","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-193","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study: Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-194","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc10-0493","article-title":"Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): A 12-month, randomized, controlled, double-masked, multicenter phase II study","author":"Massin","year":"2010","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0301-4738.245608-195","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/IAE.0000000000000116","article-title":"Systemic safety of ranibizumab for diabetic macular edema: Meta-analysis of randomized trials","author":"Yanagida","year":"2014","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-196","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.ophtha.2013.02.019","article-title":"Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: Interim analysis of the RESTORE extension study","author":"Lang","year":"2013","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-197","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.ophtha.2013.02.002","article-title":"Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema","author":"Stein","year":"2013","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-198","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/M13-0768","article-title":"Cost-effectiveness of treatment of diabetic macular edema","author":"Pershing","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0301-4738.245608-199","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3928\/23258160-20180329-05","article-title":"Frequency of bevacizumab and ranibizumab injections for diabetic macular edema in medicare beneficiaries","author":"Wu","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.4103\/0301-4738.245608-200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/IAE.0b013e31822f55de","article-title":"Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema","author":"Soheilian","year":"2012","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-201","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0161-6420(97)30289-9","article-title":"Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus","author":"Hikichi","year":"1997","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-202","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0002-9394(02)01855-X","article-title":"Resolution of diabetic cystoid macular edema associated with spontaneous vitreofoveal separation","author":"Yamaguchi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-203","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0161-6420(92)31901-3","article-title":"Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction","author":"Lewis","year":"1992","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-204","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00006982-200002000-00023","article-title":"Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid","author":"Ikeda","year":"2000","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-205","first-page":"264","article-title":"Vitrectomy results in diabetic macular oedema without evident vitreomacular traction","author":"La","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-206","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9394(00)00472-4","article-title":"Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid","author":"Pendergast","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-207","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0002-9394(14)72018-5","article-title":"Vitrectomy for diffuse macular edema in cases of diabetic retinopathy","author":"Tachi","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-208","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1167\/iovs.02-1313","article-title":"Changes in focal macular electroretinograms and foveal thickness after vitrectomy for diabetic macular edema","author":"Terasaki","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.245608-209","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0002-9394(01)01050-9","article-title":"Vitrectomy for diabetic macular edema: The role of posterior vitreous detachment and epimacular membrane","author":"Yamamoto","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-210","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ajo.2004.12.017","article-title":"Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema","author":"Yanyali","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-211","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00006982-200601000-00002","article-title":"Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema","author":"Patel","year":"2006","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-212","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0002-9394(02)01819-6","article-title":"Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema","author":"Yamamoto","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-213","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ophtha.2003.06.001","article-title":"Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema","author":"Asami","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245608-214","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.eye.6702012","article-title":"Diabetic macular oedema: Pilot randomised trial of pars plana vitrectomy vs.macular argon photocoagulation","author":"Patel","year":"2006","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245608-215","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/IAE.0b013e31816102f2","article-title":", Murray TG.Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema","author":"Hartley","year":"2008","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-216","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00006982-200002000-00004","article-title":"Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane","author":"Gandorfer","year":"2000","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-217","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00006982-200002000-00003","article-title":"Surgical treatment for severe diabetic macular edema with massive hard exudates","author":"Yang","year":"2000","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-218","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00006982-200602000-00003","article-title":"Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema","author":"Mochizuki","year":"2006","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-219","unstructured":"Landers MB 3rd, Graversen VA, Stewart MW. Early vitrectomy for DME: Does it have a role? Sometimes Vitrectomy can be First-Line Treatment. Part 1 of 2. Retina Physician; 2013."},{"key":"key-10.4103\/0301-4738.245608-220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bjo.2004.044966","article-title":"A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema","author":"Thomas","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-221","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10384-006-0366-5","article-title":"Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide","author":"Higuchi","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-222","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ajo.2005.07.043","article-title":"Vitrectomy for diabetic macular edema","author":"Shah","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-223","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/eye.2008.84","article-title":"Vitrectomy for diabetic macular oedema","author":"Laidlaw","year":"2008","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245608-224","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ajo.2018.04.010","article-title":"Vision outcomes following anti-vascular endothelial growth factor treatment of diabetic macular edema in clinical practice","author":"Holekamp","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-225","first-page":"353","article-title":"Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV","author":"Wecker","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-226","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3928\/23258160-20160229-09","article-title":"Diabetic macular edema diagnosis and treatment in the real world: An analysis of medicare claims data (2008 to 2010)","author":"Dugel","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.4103\/0301-4738.245608-227","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2147\/OPTH.S60893","article-title":"Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema","author":"Kiss","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-228","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ajo.2016.09.002","article-title":"Real-world outcomes of ranibizumab treatment for diabetic macular edema in a United Kingdom National Health Service setting","author":"Patrao","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-229","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1111\/aos.12014","article-title":"Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting","author":"Brynskov","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-230","first-page":"324841","article-title":"Ranibizumab for visual impairment due to diabetic macular edema: Real-world evidence in the Italian population (PRIDE study)","author":"Menchini","year":"2015","journal-title":"J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245608-231","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1097\/IAE.0000000000000164","article-title":"Nonmedical costs and implications for patients seeking vitreoretinalcare","author":"Smiddy","year":"2014","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245608-232","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3928\/23258160-20150730-09","article-title":"Comorbidity and health care resource use among commercially insured non-elderly patients with diabetic macular edema","author":"Wallick","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.4103\/0301-4738.245608-233","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1001\/archopht.126.12.1748","article-title":"Resource use and costs associated with diabetic macular edema in elderly persons","author":"Shea","year":"2008","journal-title":"Arch Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:35:14Z","timestamp":1787067314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1240_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":233,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"alternative-id":["245608"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1240_18","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}